We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evo... Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Show more
WINTER PARK, Fla., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for...
WINTER PARK, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company...
WINTER PARK, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”) today announced that Jeffrey S. Yarckin has notified the Company of...
WINTER PARK, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company” or “PINE”), an owner and operator of single tenant net leased commercial...
WINTER PARK, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the origination of a $40.2 million first mortgage loan with an...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.45 | 2.70758122744 | 16.62 | 17.14 | 16.36 | 104497 | 16.77040107 | CS |
4 | 0.41 | 2.46098439376 | 16.66 | 17.14 | 16.06 | 91561 | 16.70913668 | CS |
12 | -0.945 | -5.2456286428 | 18.015 | 18.24 | 16.06 | 91427 | 17.10362345 | CS |
26 | 0.17 | 1.00591715976 | 16.9 | 19.42 | 16.06 | 84137 | 17.5878308 | CS |
52 | 1.71 | 11.1328125 | 15.36 | 19.42 | 14.325 | 66973 | 16.82584816 | CS |
156 | -2.03 | -10.6282722513 | 19.1 | 20.7899 | 14.25 | 70477 | 17.21759755 | CS |
260 | -1.97 | -10.3466386555 | 19.04 | 21.069 | 7.56 | 69527 | 17.03755154 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions